Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wir
DAK-Gesundheit tender for Healthcare & Medical, value not disclosed, published in February 2026 — one of 737 records from this buyer.
Buying agency
DAK-GesundheitWinner
Sign-up only
See who won, the status and the award date.
A free account shows the winner. The status and the award date come with the US$19 3-day pass or a subscription.
Sign up free →Free account · cancel anytime
Contract description
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Levothyroxin, ATC H03AA01 für die Zeit 01.04.2026 - 31.03.2028 (zzgl. Verlängerungsoption 1x12 Monate)
Other tenders · DAK-Gesundheit
737 tendersThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
Winners and award dates are hidden on the public page. Sign up free to see them →
- ocds-ted-210283-2024€9.1M08 Feb 2024 Healthcare
- ocds-ted-211590-2024€2.5M19 Jan 2024 Healthcare
- ocds-ted-828775-2025€38.0K12 Dec 2025 IT
Sign-up only
See who won, the status and the award date.
A free account shows the winner. The status and the award date come with the US$19 3-day pass or a subscription.
Sign up free →Free account · cancel anytime